ModiQuest B.V.

Over ModiQuest B.V.

ModiQuest B.V. develops novel therapeutics for Rheumatoid Arthritis, and other inflammatory diseases, using recombinant antibody technology. ModiQuest B.V. is activily looking for partners to co-develop or outlicense several therapeutic leads for Rheumatoid Arthritis. Current leads: -anti inflammatory fully human antibody family -family of anti inflammatory peptides

Trefwoorden

• Human-Antibodies
• Inflammation
• Phage-Display
• Recombinant-Antibodies
• Rheumatoid Arthritis
• Therapeutics

Adres

• Hoofdkantoor

  Waalbandijk 1196541AK NijmegenGelderland, Nederland

Team per functiegebied

Gebaseerd op 2 openbare functieprofielen, stand van 3 september 2026.

• Operations1
• Other / Unclassifiable1